DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Uricosuric
Uricosuric
Vincristine
207988Orig1s000
Guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia DINESH KHANNA,1 JOHN D
Lesinurad Cuts Uric Acid in Refractory Gout
Antihyperuricemics Review 10/25/2010
Lesinurad Combined with Allopurinol
2020 American College of Rheumatology Guideline for the Management of Gout
204820Orig1s000
Lecture 5: Drugs in Gout
Allopurinol in Primary Gout of Uricosuric Agents
Evidence for a Postsecretory Reabsorptive Site for Uric Acid in Man
Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent Than Benzbromarone S
Interaction Between Allopurinol and Pyrazinamide
Effects of Pyrazinamide, Probenecid, and Benzbromarone on Renal Excretion of Oxypurinol
Uraemic Patients with Gout*
International Position Paper on the Appropriate Use of Uricosurics with the Introduction of Lesinurad
In Vitro Xanthine Oxidase Inhibitory and in Vivo Hypouricemic Activity of Herbal Coded Formulation (Gouticin)
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: an Evidence-Based Update
Top View
Download Product Insert (PDF)
1. Name of the Medicinal Product 2. Qualitative And
ZYLOPRIM ® (Allopurinol) 100-Mg Scored Tablets and 300-Mg Scored Tablets Rx Only
Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with Gout
PRODUCT MONOGRAPH SULFINPYRAZONE Sulfinpyrazone
Review Article the Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease
The Effects of Azathioprine (Imuran) on Purine Synthesis in Clinical Disorders of Purine Metabolism
University of Groningen Effectiveness and Safety of Medicines Used in COPD Patients Wang, Yuanyuan
Fenofibrate and Losartan That the Combination of Fenofibrate Or Losartan with Allopurinol Might Lower T Bardin the Hypouricaemic Effect of Allopurinol
The Hypotensive and Uricosuric Effect of Valsartan Compared to Losartan in Gout Patients
Effects on Uric Acid Metabolism of the Drugs Except the Antihyperuricemics
Cross Discipline Team Leader Review
Toxicity Prediction Using Multi-Disciplinary Data Integration and Novel Computational Approaches
An Overview of Uricosuric Drugs and Their Screening Methods
Xanthine Oxidase Inhibitor Step Therapy with Quantity Limit
Probenecid Tablets, USP
Probenecid Tablets, USP500 Mgrx Only
NEW URICOSURIC AGENT in the TREATMENT of GOUT Para-CARBOXYBENZENESULPHA-DIETHYLAMIDE (URELIM)
Lesinurad (Zurampic) for Gout Phung C
Refractory Gout Patients
Long Term Uricosuric T-Herapy in Gout
Evaluation of Uricosuric Agents in Chronic Gout*
No. Reference Year Country Denominator
Sodium Salicylate and Probenecid in the Treatment of Chronic Gout* Assessment of Their Relative Effects in Lowering Serum Uric Acid Levels by F
Antihyperuricemics Review – March 2020 Page 2 | Proprietary Information
Clinical Review Hyperuricemia and Gout
Uricosuric Diuretics
Anti-Gout Agents
Mutual Suppression of the Uricosuric Effects of Sulfinpyrazone and Salicylate: a Study in Interactions Between Drugs
Medication Coverage Policy
The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout
New Zealand Data Sheet
Allopurinol 100 Mg and 300 Mg Tablets
Antineoplastic Drugs